[Correspondence] Surgery for cerebral haemorrhage—STICH II trial
In the STICH II trial, an absolute benefit of 3·7% in favourable outcome and 5·6% in mortality were reported for the early surgery group, but a significant difference between surgery and conservative treatment was not reached for the primary outcome. Glasgow coma scale was the only scoring clinical indicator. Other stroke scales assessing clinical severity—ie, the National Institutes of Health scale, could be considered. Neurological severity, also in a conscious patient, is an important prognostic indicator.
Source: LANCET - Category: Journals (General) Authors: Simone Vidale, Silvio Bellocchi, Angelo Taborelli Tags: Correspondence Source Type: research
More News: General Medicine | National Institutes of Health (NIH) | Neurology | Neurosurgery | Stroke